| Literature DB >> 33447424 |
Guofang Zhao1, Xu Jiang1, Fajiu Wang1, Minghui Chu2, Chenxu Zhang2, Weidi Zhao2, Minglei Yang1, Xiang Xu1, Enkuo Zheng1, Junjun Ni1, Liangwei Yang1.
Abstract
BACKGROUND: High-position single-intercostal two-port video-assisted thoracic surgery (VATS) technique has been used for thoracic diseases. It can effectively avoid postoperative chronic pain compared with the traditional three-port VATS. This study aimed to evaluate the safety and efficacy of high-position single-intercostal two-port video-assisted thoracoscopic lobectomy.Entities:
Keywords: Video-assisted thoracoscopic surgery (VATS); efficacy; lobectomy; non-small cell lung cancer (NSCLC); safety; two-port
Year: 2020 PMID: 33447424 PMCID: PMC7797867 DOI: 10.21037/jtd-20-3469
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 3.005
Figure 1High-position single-intercostal two-port VATS. (A) Two incisions of approximately 2 cm are located at the same intercostal region’s anterior and posterior axillary lines; (B) the surgeon may operate in a seated position to relieve fatigue; (C) the two incisions share the entrance and exit of the instrument and the mirror. During operation, the instrument, the mirror, and the chest wall are almost vertically suspended; (D) a right upper sleeve lobectomy is performed, and bronchoplasty is performed by continuous suture with a 4–0 slide thread. VATS, video-assisted thoracoscopic surgery.
Figure 2Removal of larger specimens. (A) The lung tissue is first put into the specimen bag (a large gallbladder bag) then carefully lifted and cut outside the incision and in the pocket. Finally, the lung tissue is cut into two before being removed. (B,C) The extracted lung can be wholly assembled into a whole lobe.
General information of patients who underwent single-intercostal two-port thoracoscopic lobectomy
| Characteristic | Mean ± standard deviation or rate (%) |
|---|---|
| Gender | |
| Male | 168 (35.4) |
| Female | 306 (64.6) |
| Age (year) | 59.7±10.8 |
| Smoking history | |
| Never-smokers | 355 (74.9) |
| Ever-smokers | 119 (25.1) |
| Comorbidities | |
| None | 244 (51.5) |
| Hypertension | 156 (32.9) |
| Diabetes | 14 (3.0) |
| Coronary heart disease | 3 (0.6) |
| Chronic obstructive pulmonary disease | 4 (0.8) |
| Asthma | 2 (0.4) |
| Atrial fibrillation | 4 (0.8) |
| Others | 47 (10.0) |
Intraoperative parameters of patients with single-intercostal two-port video-assisted thoracoscopic lobectomy
| Characteristic | Mean ± standard deviation or rate (%) |
|---|---|
| Incised location | |
| The 3rd intercostals | 131 (27.6) |
| The 4th intercostals | 196 (41.4) |
| The 5th intercostals | 147 (31.0) |
| Excision extension | |
| Upper lobe of left lung | 77 (16.2) |
| Lower lobe of left lung | 76 (16.0) |
| Upper lobe of right lung | 177 (37.3) |
| Middle lobe of right lung | 58 (12.3) |
| Lower lobe of right lung | 75 (15.9) |
| Middle and lower lobe of right lung | 9 (1.9) |
| The left lung | 2 (0.4) |
| The lesion size (mm) | 16.6±9.8 |
| Pleural adhesions | |
| None or mild | 275 (58.0) |
| Moderate | 177 (37.3) |
| Severe | 22 (4.7) |
| Fissure development | |
| Well-developed | 343 (72.4) |
| Poorly developed | 131 (27.6) |
| Intraoperative blood loss (mL) | 67.1±48.3 |
| Surgical time (min) | 160.9±44.9 |
| Number of lymph node dissection stations | 6.8±1.6 |
| Number of lymph nodes dissected | 13.6±5.3 |
Postoperative data of patients
| Characteristic | Mean ± standard deviation or rate (%) |
|---|---|
| Postoperative hospital stay (days) | 5.6±3.4 |
| Drainage time of chest tube (days) | 3.1±2.7 |
| Complications | |
| None | 440 (92.8) |
| Delayed air leakage | 20 (4.2) |
| Delayed wound healing | 2 (0.4) |
| Pneumonia | 5 (1.1) |
| Pleural effusion | 2 (0.4) |
| Chylothorax | 2 (0.4) |
| Atrial fibrillation | 2 (0.4) |
Survival rates of patients with NSCLC at different pathological stages after single-intercostal two-port video-assisted thoracoscopic lobectomy
| Pathological stage | Overall survival (%) | Relapse-free survival (%) | |||
|---|---|---|---|---|---|
| 3-year | 5-year | 3-year | 5-year | ||
| IA1 [188] | 99.0 | 99.0 | 98.1 | 92.9 | |
| IA2 [160] | 98.6 | 94.5 | 97.2 | 90.4 | |
| IA3 [54] | 96.3 | 87.5 | 94.3 | 84.2 | |
| IB [37] | 91.2 | 85.5 | 91.0 | 79.3 | |
| IIA [7] | 85.7 | – | 80.0 | – | |
| IIB [10] | 66.7 | – | 56.3 | – | |
| IIIA [18] | 60.8 | 43.4 | 52.4 | – | |
NSCLC, non-small cell lung cancer.
Figure 3Intraoperative finger touch is used to determine the location of the pulmonary nodules.